DAFTAR PUSTAKA
1. James K.Min, MD. Coronary CTA versus cardiac catheterization: Where do We stand today? Well Medical College of Cornell University. New York- Presbyterian Hospital, New York, NY.2006
2. Libby P, Bonow RO, Mann DL.Braunwald’s heart disease: A textbook of Cardiovascular medicine. 8th ed. 2007
3. Alwi Idrus. Hanafi Muin Rahman, S Harun. Ilmu Penyakit Dalam jilid III. Penyadapan Jantung ( Cardiac Catheterization) Jakarta: FKUI 2006, hal 1491-496
4. Departemen Kesehatan RI, 2012, Penyakit Tidak Menular. In : Buletin Jendela dan Data Kesehatan ISSN 2088-207X.Jakarta: Bakti Husada 5. Karol Watson,MD,PhD, 2001.CHD Based upon the more stringent
guidelines Of ATP III,as compared to ATP II, a more aggressive
treatment strategy is warranted in dyslipidemia patient, Advanced
Studies in Medicine, JA MA ;285:2486-2497
6. Gary T, Pichler M, Belaj K.et. al. 2013. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive
disease patients. PloS One; 8: e67688.
7. Smith RA, Ghaneh P, Sutton R, et.al. 2008. Prognosis of resected ampullary Adenocarcinoma by preoperative serum CA19- 9 levels and
platelet- lymphocyte ratio. J Gastrointest Surg; 12: 1422-8.
9. Alwi Idrus, Setiati S, Sudoyo Aru W. et.al. 2014. Ilmu Penyakit Dalam.Jakarta : Internal Publishing : 1292-1293
10.McKay J, George AM, Shantu M. et.al. The atlas of heart disease and stroke. World Health Organization. Geneva; 2004
11.Acanfora D, Gheorghiade M, Trojano L. C, et al. 2001. Relative lymphocyte count: a prognostic indicator of mortality in erderly
patients with congestive heart failure. Am Heart J; 142 : 167-73
12.Nikolsky E. Grines CL, Cox DA. Impact of Baseline platelet count in patients undergoing primary percutaneous coronary interventionin
acute myocardial infarction (from the CADILLAC trial). Am J Cardiol ;
2007;99: 1055-61
13.Zouridakis EG, Garcia-Moll X, Kaski JC. Et.al.2000. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in
patients with unstable angina pectoris. Am J Cardiol; 86: 449-51
14.Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. 1991. Blood platelet count and function are related to total and
cardiovascular death in apparently healthy men. Circulation; 84:
613-7
15.Proctor MJ, Morrison DS, Talwar D. et al. 2011. A comparison of inflammation-based prognostic scores in patients with cancer. A
Glasgow Inflammation Outcome Study. Eur J Cancer; 47: 2633-41 16.Azab B, Shah N, Akerman M. 2012. Value of platelet / lymphocyte
ratio as a predictor of all-cause mortality after non-STelevation
17.Yıldız A, Yuksel M, Oylumlu M. et al. 2014 .The Utility of The platelet-lymphocyte ratio for predicting no reflow in patients with
ST-segment elevation myocardial infarction. Clin Appl Thromb Hemost
18.Yüksel M, Yıldız A, Oylumlu Mustafa. Patelet/lymphocyte ratio and CAD,Department of Cardiology, Faculty of Medicine, Dicle University;
Diyarbakır-Turkey ; Anadolu Kardiyol Derg; 2014.;14(0)
19.Rilanto L.I, Tedjokusumo. P. Patogesis Arterosklerosis. 5 Rahasia Untuk Menanggulangi Penyakit Kardiovaskular. FKUI. 2012; 127-131 20.ACC/AHA Guideline on the Assessment of Cardiovascular Risk, 2013 http://dx.doi.org/10.1161/01.cir.00000437741.48606.98
21.Falk E, Shah PK, Fuster V. Coronary Plaque Distruption. Circulation 2005; 92:657-671
22.Han YC, Yang TH, Kim DI, Jin HY, Chung SR, Seo JS, et al. 2013. Neutrophil to Lymphocyte Ratio Predicts Long-Term Clinical
Outcomes in patients with ST-Segment Elevation Myocardial
Infarction Undergoing Primary Percutaneous Coronary
Intervention.Korean Circ J; 43: 93-9.
23.Beltrame John F., Rachel Dreyer, Rosanna Tavella.et.al. 2001. Discipline of Medicine, University of Adelaide. Circulation 104: 2746-53.
25.Kumar V MD. Cotran R MD. Robin ZL MD. Basic patology. MB Saunders Co. Philadelphia. 1997. 282-92
26.Constaninides. P. The Commonest Causes of Anoxic Necrosis. Dalam: General Pathobiology Norwalk Connecticut: Appleton & Lange. 1999; 59-16
27.Ross Russel. Atherosclerosis an Inflamatory Disease. Available from:
28.Shimokawa. H. Clinical Assessment of Endothelial Function.
Available from:
29.Tuveri M. Pathophysiological Aspects of Vascular Disease. Role Hemodynamic Factor. Biomedical Application Group. METDST 1999. September 2; 18:51:14
30.Stary HC, Chandler AB, Dinsmore RE. A definition of advanced types of atherosclerotic lesions and a histological classification of
atherosclerosis: a report from the Committee on Vascular Lesions of
the Council on Arteriosclerosis, American Heart Association.
Circulation; 1995; 92:1355-74.
31.Pepine CJ. Rupture Adapted. Am J Cardiol. 1998; 82(suppl 104) 32.Libby P. Inflammation in atherosclerosis. Nature. 2002; 420:868–874. 33.Libby P, Lee RT. Matrix matters. Circulation. 2000;102:1874 –1876 34.Williams KJ, Tabas I. The response-to-retention hypothesis of
35.Berliner JA, Subbanagounder G, Leitinger N, Watson AD, Vora D. Evidence for a role of phospholipid oxidation products in atherogenesis.Trends Cardiovasc Med. 2001;11:142–147
36.Demer LL. Vascular calcification and osteoporosis: inflammatory responses to oxidized lipids. Int J Epidemiol. 2002;31:737–741
37.Geng YJ, Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol. 2002; 22: 1370 –1380 38.Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M,
Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med. 2003; 9:458–462.
39.Libby P, Ridker PM, Maseri an Inflammation and Atherosclerosis. Circulation 2005; 102:135-432 2.3.4.5.6.7.8.9.10.2011.
40.Frakter TD, Fihn SD, Gibbons RJ, Abrams J, Chatterjee K, Daley J. et al. 2002. Chronic angina focused update of the ACC/AHA 2002. Guidelines for the management of patients with chronic stable angina: a report of American College of Cardiology/American Heart Association task Force on Practice Guidelines Writing Group to develop focused of the 2002
41.Lock JE, Rome JJ, Davis R, et al. Transcatheter closure of atrial septal d efects. Experimental studies. Circulation 1989;79: 1091 1099
42.Sultan D. Sheriff, Sachu P. and Elshaari F.A. HDL, apo B / apo A1 ratio, Diabetes Mellitus and Cardiovascular
43.Arthur Selter, MD, William L. Anderson, MD, Harold W. March, MD. 2001. Indication for Coronary Arteriography Risks Vs Benefits. California Medicine. The Western Journal of Medicine. 2001
44.Guidelines for the management of the patiens with chronic stable stable angina. Circulation. 2007; 116:2762-2772
45.Hoffbrand, A.V., J.E, Pettit, P.A.H, Moss, 2005. Kapita Selekta Hematologi, Jakarta: ECG.
46.Massberg, S., et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J. Exp. Med. 2003; 197:41–49.
47.Balduini CL, Noris P. 2014. Platelet count and aging. Haematologica. 2014 Jun; 99(6):953-5.doi: 10.3324/haematol.2014.106260.
48.Kickler TS. Clinical analyzers: advances in automated cell counting. Anal Chem 1999; 71:363-5.
49.Madjid M, Fatemi O. Component of the complete blood count as risk Predictor for coronary heart disease. Text Heart Inst J 2013; 40 (1):17-29
50.Hilman Robert S, Ault Kenneth A, Rinder Henry M., hematology in clinical practice: a guide to diagnosis and management. Lange ,Mc Graw Hill, 2005 ;19;235-247
52.Frostegård J, Ulfgren AK, Nyberg P, et al. 1999.Cytokine expressio in Advanced human atherosclerotic plaques: dominance of
proinflammatory (Th1) and macrophage- stimulating cytokines.
Atherosclerosis; 145: 33-43
53.Lutters B. C. H, Ronald H. W. M. Derksen. et. al. 2003. Dimers of 2-Glycoprotein I Increase Platelet Deposition to Collagen via
Interaction with Phospholipids and the Apolipoprotein E Receptor 2.
The Journal of Biological Chemistry. The American Society For Biochemistry and Molecular, Inc. Vol. 278, pp. 33831-33838
54.Body R, Carley S, McDowell G. et.al 2011. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a
high sensitivity assay. J Am Coll Cardiol; 58: 1333-9.
55.Ommen SR, Hodge DO, Rodeheffer RJ, McGregor CG, Thomson SP, Gibbons RJ. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 1998; 97: 19-22 56.Dragu R, Khoury S, Zuckerman R, Suleiman M, Mutlak D, Agmon
Y,et al. Predictive value of white blood cell subtypes for long-term outcome following myocardial infarction. Atherosclerosis 2008; 196(1):405-12.
57.Tabas I. Nonoxidative modifications of lipoproteins in atherogenesis. Ann Rev Nutr. 1999; 19: 123–139.
59.Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK. Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scena. J Clin Pathol. 2006; 59(2):146–
60.Dahlan S. Langkah-langkah Membuat Proposal Penelitian Bidang
